SI2201376T1 - Nov biomarker za monitoring razvoja bolezni in določanje učinkovitosti terapij - Google Patents

Nov biomarker za monitoring razvoja bolezni in določanje učinkovitosti terapij

Info

Publication number
SI2201376T1
SI2201376T1 SI200830723T SI200830723T SI2201376T1 SI 2201376 T1 SI2201376 T1 SI 2201376T1 SI 200830723 T SI200830723 T SI 200830723T SI 200830723 T SI200830723 T SI 200830723T SI 2201376 T1 SI2201376 T1 SI 2201376T1
Authority
SI
Slovenia
Prior art keywords
therapies
assessing
efficacy
diseases
new biomarker
Prior art date
Application number
SI200830723T
Other languages
English (en)
Slovenian (sl)
Inventor
Sirpa Jalkanen
Marko Salmi
Markku Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Publication of SI2201376T1 publication Critical patent/SI2201376T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
SI200830723T 2007-10-24 2008-10-15 Nov biomarker za monitoring razvoja bolezni in določanje učinkovitosti terapij SI2201376T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
PCT/FI2008/050576 WO2009053523A1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
EP08842581A EP2201376B1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies

Publications (1)

Publication Number Publication Date
SI2201376T1 true SI2201376T1 (sl) 2012-09-28

Family

ID=38656804

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200830723T SI2201376T1 (sl) 2007-10-24 2008-10-15 Nov biomarker za monitoring razvoja bolezni in določanje učinkovitosti terapij
SI200831377T SI2503338T1 (sl) 2007-10-24 2008-10-15 CD73 kot biomarker za spremljanje razvoja bolezni in ocenjevanje učinkovitosti terapij

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200831377T SI2503338T1 (sl) 2007-10-24 2008-10-15 CD73 kot biomarker za spremljanje razvoja bolezni in ocenjevanje učinkovitosti terapij

Country Status (14)

Country Link
US (1) US20100209942A1 (cg-RX-API-DMAC7.html)
EP (2) EP2201376B1 (cg-RX-API-DMAC7.html)
JP (2) JP4982610B2 (cg-RX-API-DMAC7.html)
KR (2) KR20100059902A (cg-RX-API-DMAC7.html)
CA (1) CA2702635A1 (cg-RX-API-DMAC7.html)
CY (2) CY1113403T1 (cg-RX-API-DMAC7.html)
DK (2) DK2201376T3 (cg-RX-API-DMAC7.html)
ES (2) ES2532361T3 (cg-RX-API-DMAC7.html)
FI (1) FI20070795A0 (cg-RX-API-DMAC7.html)
HR (2) HRP20120743T1 (cg-RX-API-DMAC7.html)
PL (2) PL2503338T3 (cg-RX-API-DMAC7.html)
PT (2) PT2201376E (cg-RX-API-DMAC7.html)
SI (2) SI2201376T1 (cg-RX-API-DMAC7.html)
WO (1) WO2009053523A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5781767B2 (ja) 2008-01-18 2015-09-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 体液中における疾患または状態のシグネチャーを検出する方法
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
US20130184178A1 (en) 2010-07-23 2013-07-18 President And Fellows Of Harvard College Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
US20130210647A1 (en) 2010-07-23 2013-08-15 President And Fellows Of Harvard College Methods of Detecting Cardiovascular Diseases or Conditions
US20120040846A1 (en) 2010-07-23 2012-02-16 President And Fellows Of Harvard College Methods of Detecting Diseases or Conditions Using Phagocytic Cells
EP2861765B1 (en) 2012-06-15 2019-01-23 Progenity, Inc. Methods of detecting diseases or conditions
CA2876711A1 (en) 2012-06-15 2013-12-19 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
CN105164535B (zh) 2013-02-14 2018-04-10 法龙药品公司 测定急性呼吸窘迫综合征(ards)相关生物标志物的方法、监测患者的ards的发展和治疗的方法
EP3385717A3 (en) 2013-03-09 2018-10-24 Harry Stylli Methods of detecting prostate cancer
EP4202441A3 (en) 2013-03-09 2023-07-26 Immunis.AI, Inc. Gene expression profile in macrophages for the diagnosis of cancer
EP3191846A4 (en) 2014-09-11 2018-06-13 Harry Stylli Methods of detecting prostate cancer
WO2016081746A2 (en) 2014-11-21 2016-05-26 Bristol-Myers Squibb Company Antibodies comprising modified heavy constant regions
ES2807182T3 (es) 2014-11-21 2021-02-22 Bristol Myers Squibb Co Anticuerpos frente a CD73 y sus usos
GB201706747D0 (en) * 2017-04-27 2017-06-14 Queen Mary Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515965A (ja) * 1995-08-18 2002-05-28 ダブリュー． ランドリ，ドナルド 抗体触媒反応の調節による有機化合物の検出
AU7310496A (en) 1995-10-13 1997-04-30 Imperial College Of Science, Technology And Medicine Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy
HUP0002003A3 (en) 2000-05-24 2003-01-28 Pronuk Biotechnologia Kft Process and reagent-kit for determining of 5'-nucleotidase activity
AU2002252460A1 (en) * 2001-03-27 2002-10-08 Zymogenetics, Inc. Human cytokine receptor
WO2004079013A1 (en) * 2003-03-03 2004-09-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
FI20030467A0 (fi) * 2003-03-28 2003-03-28 Sirpa Jalkanen Menetelmä tulehdustilojen hoitamiseen
DE602004027797D1 (de) * 2003-03-28 2010-08-05 Faron Pharmaceuticals Oy Erhöhung des adenosin-spiegels durch cytokin-induzierte expression von cd73
US7772192B2 (en) * 2003-06-03 2010-08-10 The Regents Of The University Of California Compositions and methods for treatment of disease with acetylated disaccharides
WO2007025044A2 (en) * 2005-08-24 2007-03-01 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
FI20051003A0 (fi) 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
WO2007107598A1 (en) * 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
CA2657576C (en) * 2006-07-14 2023-10-31 The Regents Of The University Of California Cancer biomarkers and methods of use thereof

Also Published As

Publication number Publication date
PT2201376E (pt) 2012-08-20
ES2389751T3 (es) 2012-10-31
CY1116089T1 (el) 2017-02-08
KR20160029869A (ko) 2016-03-15
EP2201376A1 (en) 2010-06-30
JP4982610B2 (ja) 2012-07-25
CA2702635A1 (en) 2009-04-30
HRP20120743T1 (hr) 2012-10-31
JP2011501176A (ja) 2011-01-06
ES2532361T3 (es) 2015-03-26
US20100209942A1 (en) 2010-08-19
FI20070795A0 (fi) 2007-10-24
EP2503338A2 (en) 2012-09-26
EP2201376B1 (en) 2012-08-08
JP5619810B2 (ja) 2014-11-05
EP2201376A4 (en) 2011-03-23
DK2201376T3 (da) 2012-10-15
EP2503338A3 (en) 2013-03-13
EP2503338B1 (en) 2014-12-24
KR20100059902A (ko) 2010-06-04
DK2503338T3 (en) 2015-03-09
PL2201376T3 (pl) 2013-01-31
SI2503338T1 (sl) 2015-06-30
PL2503338T3 (pl) 2015-06-30
WO2009053523A1 (en) 2009-04-30
JP2012159514A (ja) 2012-08-23
CY1113403T1 (el) 2016-06-22
PT2503338E (pt) 2015-03-05
HRP20150181T1 (hr) 2015-06-19

Similar Documents

Publication Publication Date Title
SI2201376T1 (sl) Nov biomarker za monitoring razvoja bolezni in določanje učinkovitosti terapij
GB0724735D0 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
GB0701626D0 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
IL219210A0 (en) Biomarkers and methods for measuring and monitoring inflammatory disease activity
SG176655A1 (en) New biomarkers for assessing kidney diseases
EP2043617A4 (en) SYSTEM FOR MANAGING THERAPY AND MONITORING SUBSTANCE TO BE ANALYZED AND METHODS THEREFOR
GB2446124B (en) Device for Monitoring Respiration
GB2450351B (en) Monitoring an Immunoassay
IL179930A0 (en) Tvms - a total view monitoring system
EP2274699A4 (en) METHOD AND SYSTEMS FOR EVALUATING CLINICAL RESULTS
PL2185068T3 (pl) Monitorowanie płodu
IL195054A0 (en) Methods and apparatus for identifying disease status using biomarkers
GB0705126D0 (en) Monitoring physical activity
EP2486233A4 (en) Formation testing planning and monitoring
GB2444848B (en) Battery life monitor
GB0724200D0 (en) Battery life monitor
GB0720433D0 (en) Usage monitoring
GB0521098D0 (en) Methods for diagnosing and monitoring psychotic disorders
BRPI0814074A2 (pt) Método para a fabricação de 4-isopropil-3-metilfenol e sua utilização
EP2057570A4 (en) MONITORING CLINICAL DATA
ZA200905528B (en) Monitoring of tickets
GB0622351D0 (en) Non-invasive monitoring
GB0822087D0 (en) Monitoring computer usage
GB0822262D0 (en) Monitoring computer usage
GB0603388D0 (en) Exhaler device for monitoring disease